Combining MEK and HDAC inhibitors as a therapeutic strategy to promote differentiation of colorectal cancer.

Jenkins, Laura; Luk, Ian; Tse, Janson; Mooi, Jennifer; Dhillon, Amardeep; Mariadason, John

Combining MEK and HDAC inhibitors as a therapeutic strategy to promote differentiation of colorectal cancer.

conference contribution

posted on 2017-04-01, 00:00 authored by Laura Jenkins, Ian Luk, Janson Tse, Jennifer Mooi, Amardeep DhillonAmardeep Dhillon, John Mariadason

Combining MEK and HDAC inhibitors as a therapeutic strategy to promote differentiation of colorectal cancer.

History

Volume

77

Pagination

3089-3089

Location

Washington, D.C.

Start date

2017-04-01

End date

2017-04-05

Language

eng

Publication classification

E3 Extract of paper

Title of proceedings

AACR 2017 : Proceedings of the American Association for Cancer Research 2017 Annual Meeting

Event

American Association for Cancer Research. Annual Meeting (2017 : Washington, D.C.

Issue

13 Supplement

Publisher

American Association for Cancer Research

Place of publication

Philadephia, Pa.

Series

Cancer Research

Usage metrics

Keywords

111299 Oncology and Carcinogenesis not elsewhere classified 3211 Oncology and carcinogenesis

Combining MEK and HDAC inhibitors as a therapeutic strategy to promote differentiation of colorectal cancer.

History

Volume

Pagination

Location

Start date

End date

Language

Publication classification

Title of proceedings

Event

Issue

Publisher

Place of publication

Series

Usage metrics

Categories

Keywords

Licence

Exports